Literature DB >> 11254598

Flow cytometric determination of Panton-Valentine leucocidin S component binding.

V Gauduchon1, S Werner, G Prévost, H Monteil, D A Colin.   

Abstract

The binding of the S component (LukS-PV) from the bicomponent staphylococcal Panton-Valentine leucocidin to human polymorphonuclear neutrophils (PMNs) and monocytes was determined using flow cytometry and a single-cysteine substitution mutant of LukS-PV. The mutant was engineered by replacing a glycine at position 10 with a cysteine and was labeled with a fluorescein moiety. The biological activity of the mutant was identical to that of the native protein. It has been shown that LukS-PV has a high affinity for PMNs (Kd = 0.07 +/- 0.02 nM, n = 5) and monocytes (Kd = 0.020 +/- 0.003 nM, n = 3) with maximal binding capacities of 197,000 and 80,000 LukS-PV molecules per cell, respectively. The nonspecifically bound molecules of LukS-PV do not form pores in the presence of the F component (LukF-PV) of leucocidin. LukS-PV and HlgC share the same receptor on PMNs, but the S components of other staphylococcal leukotoxins, HlgA, LukE, and LukM, do not compete with LukS-PV for its receptor. Extracellular Ca2+ at physiological concentrations (1 to 2 nM) has only a slight influence on the LukS-PV binding, in contrast to its complete inhibition by Zn2+. The down-regulation by phorbol 12-myristate 13-acetate (PMA) of the binding of LukS-PV was blocked by staurosporine, suggesting that the regulatory effect of PMA depends on protein kinase C activation. The labeled mutant form of LukS-PV has proved very useful for detailed binding studies of circulating white cells by flow cytometry. LukS-PV possesses a high specific affinity for a unique receptor on PMNs and monocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254598      PMCID: PMC98170          DOI: 10.1128/IAI.69.4.2390-2395.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains.

Authors:  V Finck-Barbançon; G Prévost; Y Piémont
Journal:  Res Microbiol       Date:  1991-01       Impact factor: 3.992

2.  Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis.

Authors:  J Augustin; R Rosenstein; B Wieland; U Schneider; N Schnell; G Engelke; K D Entian; F Götz
Journal:  Eur J Biochem       Date:  1992-03-15

3.  Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes.

Authors:  B König; G Prévost; Y Piémont; W König
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

4.  Effects of selective protein kinase C inhibitors on the proteolytic down-regulation of L-selectin from chemoattractant-activated neutrophils.

Authors:  S R Alexander; T K Kishimoto; B Walcheck
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

5.  Characterisation of a synergohymenotropic toxin produced by Staphylococcus intermedius.

Authors:  G Prevost; T Bouakham; Y Piemont; H Monteil
Journal:  FEBS Lett       Date:  1995-12-04       Impact factor: 4.124

6.  Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation.

Authors:  D A Colin; I Mazurier; S Sire; V Finck-Barbançon
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.

Authors:  G Prévost; B Cribier; P Couppié; P Petiau; G Supersac; V Finck-Barbançon; H Monteil; Y Piemont
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Cell surface expression of fMet-Leu-Phe receptors on human neutrophils. Correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate.

Authors:  T Andersson; C Dahlgren; P D Lew; O Stendahl
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes.

Authors:  V Finck-Barbançon; G Duportail; O Meunier; D A Colin
Journal:  Biochim Biophys Acta       Date:  1993-10-20

10.  Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study.

Authors:  B Cribier; G Prévost; P Couppie; V Finck-Barbançon; E Grosshans; Y Piémont
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

View more
  40 in total

1.  Retrieving biological activity from LukF-PV mutants combined with different S components implies compatibility between the stem domains of these staphylococcal bicomponent leucotoxins.

Authors:  S Werner; D A Colin; M Coraiola; G Menestrina; H Monteil; G Prévost
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

2.  Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins.

Authors:  Benoît-Joseph Laventie; Hendrik Jan Rademaker; Maher Saleh; Ernie de Boer; Rick Janssens; Tristan Bourcier; Audrey Subilia; Luc Marcellin; Rien van Haperen; Joyce H G Lebbink; Tao Chen; Gilles Prévost; Frank Grosveld; Dubravka Drabek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 3.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants.

Authors:  Shawna F Graves; Scott D Kobayashi; Kevin R Braughton; Binh An Diep; Henry F Chambers; Michael Otto; Frank R Deleo
Journal:  Microbes Infect       Date:  2010-02-19       Impact factor: 2.700

5.  Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.

Authors:  Angelino T Tromp; Michiel Van Gent; Pauline Abrial; Amandine Martin; Joris P Jansen; Carla J C De Haas; Kok P M Van Kessel; Bart W Bardoel; Elisabeth Kruse; Emilie Bourdonnay; Michael Boettcher; Michael T McManus; Christopher J Day; Michael P Jennings; Gérard Lina; François Vandenesch; Jos A G Van Strijp; Robert Jan Lebbink; Pieter-Jan A Haas; Thomas Henry; András N Spaan
Journal:  Nat Microbiol       Date:  2018-05-07       Impact factor: 17.745

6.  Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions.

Authors:  Olivier Joubert; Gabriella Viero; Daniel Keller; Eric Martinez; Didier A Colin; Henri Monteil; Lionel Mourey; Mauro Dalla Serra; Gilles Prévost
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

7.  Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity.

Authors:  Shawna F Graves; Scott D Kobayashi; Kevin R Braughton; Adeline R Whitney; Daniel E Sturdevant; Devon L Rasmussen; Liliya N Kirpotina; Mark T Quinn; Frank R DeLeo
Journal:  J Leukoc Biol       Date:  2012-05-11       Impact factor: 4.962

8.  Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.

Authors:  Florent Meyer; Raymonde Girardot; Yves Piémont; Gilles Prévost; Didier A Colin
Journal:  Infect Immun       Date:  2008-10-06       Impact factor: 3.441

9.  Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.

Authors:  Adriana Badarau; Harald Rouha; Stefan Malafa; Derek T Logan; Maria Håkansson; Lukas Stulik; Ivana Dolezilkova; Astrid Teubenbacher; Karin Gross; Barbara Maierhofer; Susanne Weber; Michaela Jägerhofer; David Hoffman; Eszter Nagy
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

Review 10.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.